期刊文献+

氯吡格雷在冠心病患者中的应用及对药物不良反应发生率的影响研究 被引量:1

The Application of Clopidogrel in Patients with Coronary Heart Disease and Its Influence on the Incidence of Adverse Drug Reactions
下载PDF
导出
摘要 近年来,由于社会的不断发展,人们饮食习惯及生活方式也逐渐发生转变,心理压力和工作压力不断增长,导致冠心病患者逐年呈上升的趋势。冠心病具有高发病率、高致残率以及高死亡率,相关文献报道,高血压对冠心病的发病有着关键作用,提示临床治疗中应以控制患者血压、血脂水平为原则。随着我国医疗事业的不断发展,医学上对于冠心病的研究也逐渐深入,加大了人们对于冠心病发病机制、预防方法、治疗措施等知识的了解。对于冠心病患者来说,及时发现、诊断和治疗,能够有效地提高患者的生存概率,改善患者的预后。目前临床上主要通过药物治疗冠心病,本研究主要分析近年来氯吡格雷等药物治疗冠心病的效果及安全性,力求为临床治疗提供可靠的依据。 In recent years, because of the continuous development of society, people's eating habits and lifestyle have gradually changed, psychological pressure and work pressure are increasing, leading to the trend of patients with coronary heart disease year by year. Coronary heart disease has high morbidity, high disability rate and high mortality. Related literature reports that hypertension plays a key role in the pathogenesis of coronary heart disease. It is suggested that the principle of controlling the blood pressure and blood lipid level should be used in the clinical treatment. With the continuous development of medical service in China, medical research on coronary heart disease has gradually deepened, increasing people's knowledge about the pathogenesis, prevention methods and treatment measures of coronary heart disease. For patients with coronary heart disease, timely detection, diagnosis and treatment can effectively improve the survival rate of patients and improve the prognosis of patients. At present, drugs are mainly used in the treatment of coronary heart disease. This study mainly analyzes the effect and safety of clopidogrel on coronary heart disease in recent years, and strives to provide a reliable basis for clinical treatment.
作者 段昆 DUAN Kun(The People's Hospital of Shiping County,Shiping,Yunnan,66220)
出处 《智慧健康》 2018年第17期66-67,共2页 Smart Healthcare
关键词 氯吡格雷 冠心病 药物不良反应 Clopidogrel Coronary heart disease Adverse drug reactions
  • 相关文献

参考文献10

二级参考文献80

  • 1孟宪刚,王莉.氯吡格雷抵抗对老年冠心病合并糖尿病患者冠脉介入治疗预后的影响及危险因素[J].中国老年学杂志,2014,34(9):2321-2322. 被引量:28
  • 2兰亚明.糖尿病合并冠心病患者药物洗脱支架术后应用氯吡格雷的疗效[J].中国老年学杂志,2015,35(1):65-68. 被引量:23
  • 3中华医学会心血管学分会,中华心血管病杂志编辑委员会.2013抗血小板治疗中国专家共识.中华心血管病杂志,2013,41:183-194.
  • 4Fox KA,Fitzgerald G,Puymirat E,et al.Should patients with acute coronary disease be stratified for management according to their risk?Derivation,external validation and outcomes using the updated GRACE risk score.BMJ Open,2014,4:e004425.
  • 5Bergmeijer TO,Janssen PW,Schipper JC,et al.CYP2C19genotype-guided antiplatelet therapy in ST-segment elevation myocardial infarction patients-Rationale and design of the Patient Outcome after primary PCI(POPular)Genetics study.Am Heart J,2014,168:16-22.
  • 6Wright RS,Anderson JL,Adams CD,et al.2011ACCF/AHA focused update incorporated into the ACC/AHA 2007Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.developed in collaboration with the American Academy of Family Physicians,Society for Cardiovascular Angiography and Interventions,and the Society of Thoracic Surgeons.J Am Coll Cardiol,2011,57:e215-e367.
  • 7Jiang XL,Samant S,Lesko LJ,et al.Clinical pharmacokinetics and pharmacodynamics of clopidogrel.Clin Pharmacokinet,2015,54:147-166.
  • 8Mega JL,Simon T.Pharmacology of antithrombotic drugs:an assessment of oral antiplatelet and anticoagulant treatments.Lancet,2015,386:281-291.
  • 9Howell LA,Stouffer GA,Polasek M,et al.Review of clopidogrel dose escalation in the current era of potent P2Y12inhibitors.Expert Rev Clin Pharmacol,2015,8:411-421.
  • 10Zhuang XD,Long M,Li CL,et al.Efficacy and safety of lowdose clopidogrel after 12-month dual antiplatelet therapy for patients having drug-eluting stent implantation.J Thorac Dis,2014,6:459-465.

共引文献54

同被引文献10

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部